Who owns GLOBUS MEDICAL INC?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of GMED from SEC Form 13F filings across 598 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 598 institutions disclosed 118.9M shares of GLOBUS MEDICAL INC worth $9.42B — about 88.1% of shares outstanding; the largest disclosed holder is BlackRock, Inc.. Source: SEC Form 13F filings, parsed by EvidInvest.
598
13F holders
$9.42B
value, 2026 filers
88.1%
of shares outstanding (118.9M sh)
90
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of GMED's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 10.8M | $853.8M | 0.0% | 8% | +2.9% |
| 2 | Jupiter Topco LLCNEW | 8.2M | $647.9M | 0.3% | 6.1% | new |
| 3 | VANGUARD CAPITAL MANAGEMENT LLC | 5.1M | $403.5M | 0.0% | 3.8% | +1.5% |
| 4 | VANGUARD PORTFOLIO MANAGEMENT LLC | 5.0M | $394.6M | 0.0% | 3.7% | +2.4% |
| 5 | Invesco Ltd. | 4.3M | $340.5M | 0.0% | 3.2% | -0.2% |
| 6 | KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLCNEW | 4.3M | $338.1M | 1.1% | 3.2% | new |
| 7 | STATE STREET CORP | 3.7M | $293.5M | 0.0% | 2.8% | +3.4% |
| 8 | Sculptor Capital LP | 3.0M | $237.0M | 1.9% | 2.2% | -1.9% |
| 9 | JPMORGAN CHASE & CO | 2.7M | $230.8M | 0.0% | 2% | +5.7% |
| 10 | BANK OF MONTREAL /CAN/ | 2.4M | $191.6M | 0.1% | 1.8% | +5.1% |
| 11 | ALLIANCEBERNSTEIN L.P. | 2.4M | $205.1M | 0.1% | 1.8% | +36.0% |
| 12 | DIMENSIONAL FUND ADVISORS LP | 2.4M | $187.3M | 0.0% | 1.8% | +33.9% |
| 13 | GEODE CAPITAL MANAGEMENT, LLC | 2.2M | $170.2M | 0.0% | 1.6% | +1.9% |
| 14 | GOLDMAN SACHS GROUP INC | 1.8M | $140.8M | 0.0% | 1.3% | +57.4% |
| 15 | ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 1.7M | $135.6M | 0.1% | 1.3% | +88.0% |
| 16 | Boston Trust Walden Corp | 1.6M | $124.3M | 0.9% | 1.2% | +25.4% |
| 17 | Allspring Global Investments Holdings, LLC | 1.6M | $119.4M | 0.2% | 1.2% | +267.2% |
| 18 | Boston PartnersNEW | 1.6M | $122.8M | 0.1% | 1.2% | new |
| 19 | GW&K Investment Management, LLC | 1.5M | $114.8M | 0.9% | 1.1% | -2.8% |
| 20 | GENEVA CAPITAL MANAGEMENT LLC | 1.4M | $112.0M | 2.6% | 1% | -19.5% |
| 21 | WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 1.3M | $101.5M | 0.3% | 1% | -36.1% |
| 22 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1.2M | $98.5M | 0.0% | 0.9% | +0.2% |
| 23 | Quantinno Capital Management LP | 1.2M | $96.3M | 0.1% | 0.9% | +122.8% |
| 24 | NORGES BANKNEW | 1.1M | $89.0M | 0.0% | 0.8% | new |
| 25 | FULLER & THALER ASSET MANAGEMENT, INC. | 1.1M | $88.1M | 0.2% | 0.8% | +1.2% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.